L.EricksonB
[DOI] [PubMed] [Google Scholar] 5.Karaca M., Magnan C., Kargar C
It demands commitment to lifestyle changes, consistent medication use, and ongoing medical supervision to monitor progress and adjust treatment as needed
The effect of glucagon-like peptide-1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: an updated systematic review and meta-analysis
In contrast to other AOMs, which either suppress appetite or inhibit fat absorption [23], GLP-1RAs reduce body weight in a number of ways, decreasing appetite and hunger, and increasing satiety, resulting in reduced energy intake [24,25,26]
I believe period tracking apps could and should play a role in the monitoring of hormonal health in patients taking new medications, primarily because these apps collect information over time directly from the person using them, helping to spot trends, unusual events, and individual differences